SYRE Archived Articles
Spyre Therapeutics, Inc. (NASDAQ: SYRE): Pioneering Next-Generation Therapies for Inflammatory Bowel Disease and Beyond
Published on March 14, 2025
Spyre Therapeutics (SYRE): Building a Pioneering Pipeline of Novel Antibodies for Inflammatory Bowel Disease
Published on November 17, 2024
Spyre Therapeutics, Inc. (SYRE): A Promising Preclinical Biotech Poised to Transform Inflammatory Bowel Disease Treatment
Published on September 24, 2024